The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
New study center in Hamburg
The Asklepios Klinik St. Georg in Hamburg has recently been recruited as a new study center for the Post Market Clinical Follow-Up Study (PMCF study).
After clinical proof of concept in an observational study at the The Medical Center – University of Freiburg, CE approval of the CARL System followed in 2020, as well as the start of the PMCF study at initially four European centers. The following twelve study centers are now participating in the study:
Asklepios Klinik St. Georg in Hamburg
University Hospital of Düsseldorf
University Hospital Essen
University Hospital Bochum Bergmannsheil
University Hospital München-Großhadern
Klinik Bad Oeynhausen
University Hospital of Gießen
The Medical Center – University of Freiburg
Regensburg University Hospital
Kepler University Hospital (Austria)
Erasmus University Medical Center in Rotterdam (Netherlands)